pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-4291 |
Genomic Coordinates | chr9: 93819357 - 93819421 |
Description | Homo sapiens miR-4291 stem-loop |
Comment | None |
RNA Secondary Structure |
Mature miRNA Information | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-4291 | ||||||||||||
Sequence | 11| UUCAGCAGGAACAGCU |26 | ||||||||||||
Evidence | Experimental | ||||||||||||
Experiments | SOLiD | ||||||||||||
SNPs in miRNA |
|
||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | TAF1D | ||||||||||||||||||||
Synonyms | JOSD3, RAFI41, TAF(I)41, TAFI41 | ||||||||||||||||||||
Description | TATA-box binding protein associated factor, RNA polymerase I subunit D | ||||||||||||||||||||
Transcript | NM_024116 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on TAF1D | |||||||||||||||||||||
3'UTR of TAF1D (miRNA target sites are highlighted) |
>TAF1D|NM_024116|3'UTR 1 CAGGATCATGAATGTCAAAGGTGAAGCATATAGAAAAAACGACTTCATAGAAATGAATAAAGATAAATGTGGATATATGT 81 ACCAGTCTGGTGGTGAAGAAATTCTGAAACCCAGAACTTTATAACAAGAAAAAAAATTTTTAACCCTGTGAAGAAGTTTG 161 TGAAAGAAACTTGTGAAGTAGTAATAATTAGAAAAAAAACCATTAAAACACCAGAGAAAATACATAGAAAAAAAAAAAAA 241 AAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 79101.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM714646. RNA binding protein: AGO2. Condition:mildMNase
"PAR-CLIP data was present in GSM714647. RNA binding protein: AGO2. Condition:mildMNase
... - Kishore S; Jaskiewicz L; Burger L; Hausser et al., 2011, Nature methods. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Kishore S; Jaskiewicz L; Burger L; Hausser et al. - Nature methods, 2011
Cross-linking and immunoprecipitation (CLIP) is increasingly used to map transcriptome-wide binding sites of RNA-binding proteins. We developed a method for CLIP data analysis, and applied it to compare CLIP with photoactivatable ribonucleoside-enhanced CLIP (PAR-CLIP) and to uncover how differences in cross-linking and ribonuclease digestion affect the identified sites. We found only small differences in accuracies of these methods in identifying binding sites of HuR, which binds low-complexity sequences, and Argonaute 2, which has a complex binding specificity. We found that cross-link-induced mutations led to single-nucleotide resolution for both PAR-CLIP and CLIP. Our results confirm the expectation from original CLIP publications that RNA-binding proteins do not protect their binding sites sufficiently under the denaturing conditions used during the CLIP procedure, and we show that extensive digestion with sequence-specific RNases strongly biases the recovered binding sites. This bias can be substantially reduced by milder nuclease digestion conditions.
LinkOut: [PMID: 21572407]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | HEK293 |
Disease | 79101.0 |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
Experimental Support 3 for Functional miRNA-Target Interaction | |
---|---|
miRNA:Target | ---- |
Validation Method |
|
Conditions | TZM-bl |
Location of target site | 3'UTR |
Tools used in this research | TargetScan , miRTarCLIP , Piranha |
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
CLIP-seq Support 1 for dataset GSM714646 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repA |
Location of target site | ENST00000448108.2 | 3UTR | UUCAGAUGAUGAAUUUAACUGUUCAACUGCUGAAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 2 for dataset GSM714647 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | HEK293 / mildMNase, repB |
Location of target site | ENST00000448108.2 | 3UTR | UUCAGAUGAUGAAUUUAACUGUUCAACUGCUGAAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 21572407 / GSE28865 |
CLIP-seq Viewer | Link |
CLIP-seq Support 3 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000448108.2 | 3UTR | UUCAGAUGAUGAAUUUAACUGUUCAACUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
CLIP-seq Support 4 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000448108.2 | 3UTR | UUCAGAUGAUGAAUUUAACUGUUCAACUGCUGAAUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
82 hsa-miR-4291 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT102445 | CALU | calumenin | 2 | 4 | ||||||||
MIRT108677 | ZBTB33 | zinc finger and BTB domain containing 33 | 2 | 4 | ||||||||
MIRT125969 | SHOC2 | SHOC2, leucine rich repeat scaffold protein | 2 | 6 | ||||||||
MIRT179018 | PAFAH1B2 | platelet activating factor acetylhydrolase 1b catalytic subunit 2 | 2 | 4 | ||||||||
MIRT379033 | CDK6 | cyclin dependent kinase 6 | 2 | 6 | ||||||||
MIRT442473 | CPEB4 | cytoplasmic polyadenylation element binding protein 4 | 2 | 2 | ||||||||
MIRT442910 | PCBD2 | pterin-4 alpha-carbinolamine dehydratase 2 | 2 | 2 | ||||||||
MIRT442979 | ZNF736 | zinc finger protein 736 | 2 | 2 | ||||||||
MIRT445663 | TNFSF15 | TNF superfamily member 15 | 2 | 2 | ||||||||
MIRT446237 | FZD6 | frizzled class receptor 6 | 2 | 2 | ||||||||
MIRT448860 | FAM49B | family with sequence similarity 49 member B | 2 | 2 | ||||||||
MIRT455559 | TRAF1 | TNF receptor associated factor 1 | 2 | 2 | ||||||||
MIRT459704 | ZNF641 | zinc finger protein 641 | 2 | 2 | ||||||||
MIRT460608 | FEM1A | fem-1 homolog A | 2 | 2 | ||||||||
MIRT462251 | LAMA4 | laminin subunit alpha 4 | 2 | 2 | ||||||||
MIRT462469 | FIZ1 | FLT3 interacting zinc finger 1 | 2 | 2 | ||||||||
MIRT466656 | TAF1D | TATA-box binding protein associated factor, RNA polymerase I subunit D | 2 | 6 | ||||||||
MIRT466841 | STX6 | syntaxin 6 | 2 | 2 | ||||||||
MIRT471403 | PDP2 | pyruvate dehyrogenase phosphatase catalytic subunit 2 | 2 | 2 | ||||||||
MIRT471517 | PCGF3 | polycomb group ring finger 3 | 2 | 2 | ||||||||
MIRT471681 | PABPN1 | poly(A) binding protein nuclear 1 | 2 | 2 | ||||||||
MIRT472858 | MTHFD2 | methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 2, methenyltetrahydrofolate cyclohydrolase | 2 | 2 | ||||||||
MIRT474813 | KIAA0226 | RUN and cysteine rich domain containing beclin 1 interacting protein | 2 | 2 | ||||||||
MIRT474931 | KCTD15 | potassium channel tetramerization domain containing 15 | 2 | 2 | ||||||||
MIRT475814 | HDGF | heparin binding growth factor | 2 | 2 | ||||||||
MIRT480434 | C17orf49 | chromosome 17 open reading frame 49 | 2 | 2 | ||||||||
MIRT480903 | BCL2L2-PABPN1 | BCL2L2-PABPN1 readthrough | 2 | 2 | ||||||||
MIRT481478 | ARL8B | ADP ribosylation factor like GTPase 8B | 2 | 2 | ||||||||
MIRT484982 | UBE2V1 | ubiquitin conjugating enzyme E2 V1 | 2 | 8 | ||||||||
MIRT485019 | TMEM189-UBE2V1 | TMEM189-UBE2V1 readthrough | 2 | 8 | ||||||||
MIRT485036 | TMEM189 | transmembrane protein 189 | 2 | 8 | ||||||||
MIRT495074 | HEYL | hes related family bHLH transcription factor with YRPW motif-like | 2 | 2 | ||||||||
MIRT496004 | CD180 | CD180 molecule | 2 | 2 | ||||||||
MIRT500675 | TRIM37 | tripartite motif containing 37 | 2 | 2 | ||||||||
MIRT504544 | ZNF417 | zinc finger protein 417 | 2 | 6 | ||||||||
MIRT506782 | KLHL15 | kelch like family member 15 | 2 | 6 | ||||||||
MIRT507256 | FGF2 | fibroblast growth factor 2 | 2 | 6 | ||||||||
MIRT507386 | EN2 | engrailed homeobox 2 | 2 | 2 | ||||||||
MIRT512505 | BTBD19 | BTB domain containing 19 | 2 | 2 | ||||||||
MIRT516903 | CTSB | cathepsin B | 2 | 2 | ||||||||
MIRT528124 | PPP1R10 | protein phosphatase 1 regulatory subunit 10 | 2 | 2 | ||||||||
MIRT528874 | ATF3 | activating transcription factor 3 | 2 | 2 | ||||||||
MIRT536091 | MBOAT2 | membrane bound O-acyltransferase domain containing 2 | 2 | 2 | ||||||||
MIRT541079 | RLIM | ring finger protein, LIM domain interacting | 2 | 2 | ||||||||
MIRT541099 | RAF1 | Raf-1 proto-oncogene, serine/threonine kinase | 2 | 2 | ||||||||
MIRT545360 | LIN7C | lin-7 homolog C, crumbs cell polarity complex component | 2 | 2 | ||||||||
MIRT545831 | ZNF367 | zinc finger protein 367 | 2 | 4 | ||||||||
MIRT547115 | PHLPP2 | PH domain and leucine rich repeat protein phosphatase 2 | 2 | 2 | ||||||||
MIRT547312 | NPTN | neuroplastin | 2 | 2 | ||||||||
MIRT547959 | HIGD1A | HIG1 hypoxia inducible domain family member 1A | 2 | 4 | ||||||||
MIRT549943 | RPL7L1 | ribosomal protein L7 like 1 | 2 | 2 | ||||||||
MIRT550749 | ENTPD1 | ectonucleoside triphosphate diphosphohydrolase 1 | 2 | 2 | ||||||||
MIRT565145 | TUBB2A | tubulin beta 2A class IIa | 2 | 2 | ||||||||
MIRT571050 | POLQ | DNA polymerase theta | 2 | 2 | ||||||||
MIRT571361 | ZNF45 | zinc finger protein 45 | 2 | 2 | ||||||||
MIRT610133 | FOXI2 | forkhead box I2 | 2 | 2 | ||||||||
MIRT613145 | DSE | dermatan sulfate epimerase | 2 | 2 | ||||||||
MIRT613379 | ABCC12 | ATP binding cassette subfamily C member 12 | 2 | 2 | ||||||||
MIRT615752 | C6 | complement C6 | 2 | 2 | ||||||||
MIRT616460 | ADRA2B | adrenoceptor alpha 2B | 2 | 2 | ||||||||
MIRT616719 | FEM1B | fem-1 homolog B | 2 | 2 | ||||||||
MIRT618312 | IPP | intracisternal A particle-promoted polypeptide | 2 | 2 | ||||||||
MIRT631491 | RASSF4 | Ras association domain family member 4 | 2 | 2 | ||||||||
MIRT643134 | PLCXD2 | phosphatidylinositol specific phospholipase C X domain containing 2 | 2 | 2 | ||||||||
MIRT643482 | DISC1 | disrupted in schizophrenia 1 | 2 | 2 | ||||||||
MIRT649715 | TWSG1 | twisted gastrulation BMP signaling modulator 1 | 2 | 2 | ||||||||
MIRT653542 | SLC38A7 | solute carrier family 38 member 7 | 2 | 2 | ||||||||
MIRT666307 | SLC22A3 | solute carrier family 22 member 3 | 2 | 2 | ||||||||
MIRT692005 | NAP1L4 | nucleosome assembly protein 1 like 4 | 2 | 2 | ||||||||
MIRT696838 | ARL2BP | ADP ribosylation factor like GTPase 2 binding protein | 2 | 2 | ||||||||
MIRT698204 | TMEM248 | transmembrane protein 248 | 2 | 2 | ||||||||
MIRT703316 | GDPD5 | glycerophosphodiester phosphodiesterase domain containing 5 | 2 | 2 | ||||||||
MIRT709376 | FAM13A | family with sequence similarity 13 member A | 2 | 2 | ||||||||
MIRT710112 | MED23 | mediator complex subunit 23 | 2 | 2 | ||||||||
MIRT711975 | HOMER2 | homer scaffolding protein 2 | 2 | 2 | ||||||||
MIRT712275 | PPIP5K2 | diphosphoinositol pentakisphosphate kinase 2 | 2 | 2 | ||||||||
MIRT714108 | TMED9 | transmembrane p24 trafficking protein 9 | 2 | 2 | ||||||||
MIRT719113 | MAML1 | mastermind like transcriptional coactivator 1 | 2 | 2 | ||||||||
MIRT719727 | SLC39A11 | solute carrier family 39 member 11 | 2 | 2 | ||||||||
MIRT720018 | TFAP2C | transcription factor AP-2 gamma | 2 | 2 | ||||||||
MIRT720358 | ZBTB8B | zinc finger and BTB domain containing 8B | 2 | 2 | ||||||||
MIRT720372 | NUDT3 | nudix hydrolase 3 | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|